How Peptides Are Stored: Handling and Stability in the Literature

This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about health, treatment or the handling of any substance. Nothing below is a protocol, a recommendation or a handling instruction. It is a summary of what published stability studies examined and reported, written so that readers can understand the vocabulary and the measurements used in that literature.

What "storage" means in the stability literature

In published work, storage is not a single variable. It is a combination of the physical state of the material (a dried solid versus a solution), the temperature at which it is held, the buffer or matrix surrounding it, the excipients present, the container and headspace, and the mechanical and thermal history the sample has already experienced. A 2020 review of antibody stability in Biochimie analysed these influences together and discussed both the analytical methods used to detect instability and the formulation strategies researchers have tried to improve it (PMID 32891698). A 2023 laboratory methods chapter set out procedures for the storage and lyophilization of pure proteins, framing drying and cold storage as complementary techniques rather than alternatives (PMID 37647008).

Because peptides differ enormously in sequence, length, charge and hydrophobicity, the literature generally treats stability as formulation-specific: what researchers reported for one molecule in one buffer is not automatically transferable to another. That caveat runs through most of the papers summarised here.

Unreconstituted material: what studies describe about the dry state

The dominant approach described for long-term storage of peptides and proteins is lyophilization — freeze-drying the material into a solid cake. A 2021 paper in Bioanalysis examined freeze-drying specifically as a way of increasing the robustness, reliability and storage stability of critical laboratory reagents, and the researchers reported that the dried format addressed practical problems of reagent consistency over time (PMID 33890493). The same logic underlies the protocols described in the 2023 Methods in Molecular Biology chapter on storage and lyophilization of pure proteins (PMID 37647008).

Drying is itself a stress

An important point in this literature is that removing water is not neutral. The freezing and dehydration steps can unfold or aggregate a molecule even though the end product looks like a stable powder. A 2024 study in Molecular Pharmaceutics investigated how lyophilized Escherichia coli adenylate kinase could be protected during and after drying, treating the enzyme as a model for formulation design (PMID 38805365). The study framework there is typical: researchers compared formulations and measured what survived the process rather than assuming that a dry solid is inert.

Xeroprotectants and cryoprotectants

Because drying is a stress, the literature devotes considerable attention to the excipients added before lyophilization. A 2019 PLoS One paper characterised dextranol as an inert xeroprotectant, examining a protective agent intended to shield biomolecules during dehydration without participating chemically in the system (PMID 31490977). In a different modality, a 2023 study in Biomaterials Science reported that successful batch and continuous lyophilization of mRNA lipid-nanoparticle formulations depended on the cryoprotectants used and on the ionizable lipid present, which the researchers took as evidence that drying outcomes are formulation-dependent rather than process-dependent alone (PMID 37073472).

Alternatives to the cold chain

Some work asks whether cold storage can be avoided altogether. A 2024 paper in Molecules examined thermal stabilisation of lysozyme through ensilication — encasing the protein in a silica matrix — as a strategy for protecting a model protein against thermal challenge (PMID 39275055). Studies of this type are usually described by their authors as proof-of-concept for particular model molecules, not as general storage solutions.

Refrigerated and frozen conditions in published work

Stability studies commonly compare storage temperatures rather than nominating one. The 2020 Biochimie review discussed temperature among the influences on antibody stability alongside analytical approaches for detecting the resulting changes, and it also considered freezing and thawing as a distinct stress rather than a neutral transfer step (PMID 32891698). The practical reason freeze–thaw is treated separately is that ice formation concentrates solutes and creates new interfaces, both of which can promote unfolding independently of the nominal storage temperature.

The 2023 methods chapter on pure proteins similarly presents cold storage and lyophilization as laboratory options with different trade-offs — a frozen solution avoids the drying stress but retains a freeze–thaw burden, while a dried solid moves the stress to the manufacturing step (PMID 37647008). Readers encountering informal claims that one temperature is universally correct will find that the published work is more conditional than that.

Reconstituted peptides: what solution-state studies report

Once a dried peptide is dissolved, the degradation clock described in the literature runs differently. A 2022 study in Food Chemistry measured denaturation kinetics and storage stability of osteopontin in reconstituted infant milk formula, and the researchers reported kinetic behaviour — that is, loss measured as a function of temperature and time rather than as a single expiry point (PMID 35063849). Kinetic framing is the standard way solution stability is expressed in this field.

Handling history can persist

One of the more counterintuitive findings concerns memory effects. A 2019 Molecular Pharmaceutics study examined peptide oligomerization memory effects and their impact on the physical stability of the GLP-1 agonist liraglutide, and the study reported that the association state a peptide had previously adopted influenced subsequent physical stability (PMID 30990695). In other words, the literature describes solution stability as depending partly on what happened to the sample earlier, not only on its current conditions.

Solvent composition

The diluent matters as much as the temperature. A 2022 Pharmaceutics paper combined computational and experimental evaluation of the stability of a GLP-1-like peptide in ethanol–water mixtures, and the researchers reported that co-solvent composition was a measurable determinant of peptide behaviour in solution (PMID 35890357). Comparable modelling-plus-measurement designs are increasingly common where a formulation variable is difficult to isolate experimentally.

Buffers and pH

Buffer choice is a recurring theme. A 2008 study in the Journal of Pharmaceutical Sciences described self-buffering antibody formulations, in which the protein itself provided buffering capacity in place of conventional buffer species (PMID 18023013). More recently, a 2024 paper in the Journal of Immunological Methods reported a long-term investigation of formulation buffers intended to mitigate stability issues affecting conjugated critical reagents (PMID 39153729). Both illustrate that "stored in solution" is an incomplete description unless the solution is specified.

Degradation pathways: What Studies Report

Published stability work generally tracks physical changes (aggregation, oligomerization, precipitation, unfolding) separately from chemical changes (covalent modification of the sequence). The 2019 liraglutide study reported oligomerization behaviour as a physical-stability endpoint (PMID 30990695), while the 2022 osteopontin work reported denaturation as a kinetic process in a reconstituted matrix (PMID 35063849). The 2020 antibody review collected the analytical methods used to detect such changes and the formulation levers researchers have used to reduce them (PMID 32891698). None of these papers describe outcomes in people; they describe what happens to molecules in containers.

Variables examined across the cited studies

Points that recur in informal online discussion

Discussion threads about peptide handling tend to reduce a complex topic to fixed rules — powder versus solution, fridge versus freezer, how many days a vial "lasts". The published literature does not generally produce answers in that form. Instead it reports measured loss curves under specified conditions for specified molecules, as in the kinetic treatment of a reconstituted protein reported in 2022 (PMID 35063849), or comparative formulation screens such as the long-term buffer investigation reported in 2024 (PMID 39153729). Three mismatches are worth noting.

• Generalisation across molecules. Findings for one protein or lipid nanoparticle system were reported as depending on the specific excipients and lipids used (PMID 37073472).
• Ignoring the diluent. Solvent composition was itself a measured stability variable in the ethanol–water study (PMID 35890357).
• Assuming dry means stable. Work on lyophilized enzymes and on xeroprotectants exists precisely because dehydration can damage the molecule (PMID 38805365, PMID 31490977).

Limitations of this evidence

Most of the studies summarised here used antibodies, model enzymes, food proteins or nanoparticle formulations rather than the research peptides discussed in consumer settings, and several were laboratory or reagent-manufacturing papers rather than clinical pharmacy studies — including the reagent freeze-drying work reported in 2021 (PMID 33890493) and the protein storage protocols compiled in 2023 (PMID 37647008). Analytical methods also differ between papers, which the 2020 review noted as a factor in how stability results are interpreted (PMID 32891698). Readers should treat the material above as background on how stability is studied and described, not as guidance for any personal decision. Licensed clinicians and pharmacists are the appropriate source for anything relating to an actual product.

References

• Antibody stability: A key to performance - Analysis, influences and improvement (Biochimie, 2020)
• Self-buffering antibody formulations (Journal of Pharmaceutical Sciences, 2008)
• Protecting Lyophilized Escherichia coli Adenylate Kinase (Molecular Pharmaceutics, 2024)
• Dextranol: An inert xeroprotectant (PLoS One, 2019)
• Storage and Lyophilization of Pure Proteins (Methods in Molecular Biology, 2023)
• Computational and Experimental Evaluation of the Stability of a GLP-1-like Peptide in Ethanol-Water Mixtures (Pharmaceutics, 2022)
• Denaturation kinetics and storage stability of Osteopontin in reconstituted infant milk formula (Food Chemistry, 2022)
• Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids (Biomaterials Science, 2023)
• Peptide Oligomerization Memory Effects and Their Impact on the Physical Stability of the GLP-1 Agonist Liraglutide (Molecular Pharmaceutics, 2019)
• Increasing robustness, reliability and storage stability of critical reagents by freeze-drying (Bioanalysis, 2021)
• Thermal Stabilisation of Lysozyme through Ensilication (Molecules, 2024)
• Long term investigation of formulation buffers to mitigate stability issues of conjugated critical reagents (Journal of Immunological Methods, 2024)